Ferry Lalezari

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 984 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 889 citations · Full text

Medicine, Immunology, Oncology +17

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Stefano Trebeschi, Silvia Girolama Drago, Nicolai J. Birkbak et al. · Annals of Oncology · 2019 · 558 citations · Full text

Medicine, Oncology, Radiology +17

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 536 citations · Full text

Medicine, Immunology, Oncology +17

Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial

Maria Disselhorst, Josine M.M.F. Quispel-Janssen, Ferry Lalezari et al. · The Lancet Respiratory Medicine · 2019 · 252 citations

Medicine, Oncology, Pharmacology +11